Conference item : Abstract
™LenticlairT-ON: an extension trial examining long-term safety and efficacy outcomes associated with an inhaled F/HN-pseudotyped lentiviral vector for CF gene therapy in people with CF
- Publication status:
- Published
Actions
Access Document
- Publisher copy:
- 10.1089/hum.2024.63331.oab
Authors
- Publisher:
- Mary Ann Liebert
- Host title:
- ESGCT 31st Annual Congress In collaboration with SITGEC Rome, Italy October 22–25, 2024
- Journal:
- Human Gene Therapy More from this journal
- Volume:
- 36
- Issue:
- 3-4
- Pages:
- E352-E353
- Publication date:
- 2025-02-10
- Event title:
- 31st ESGCT Annual Congress (ESGCT 2024)
- Event location:
- Rome, Italy
- Event website:
- https://www.esgct.eu/post/2024-rome
- Event start date:
- 2024-10-22
- Event end date:
- 2024-10-25
- DOI:
- EISSN:
-
1557-7422
- ISSN:
-
1043-0342
- Language:
-
English
- Subtype:
-
Abstract
- Pubs id:
-
2124095
- Local pid:
-
pubs:2124095
- Deposit date:
-
2026-03-26
- ARK identifier:
Terms of use
- Copyright holder:
- Mary Ann Liebert, Inc., publishers
- Copyright date:
- 2025
- Rights statement:
- Copyright 2025, Mary Ann Liebert, Inc., publishers.
If you are the owner of this record, you can report an update to it here: Report update to this record